Abstract:Introduction Endothelial damage/dysfunction is a key event in cardiovascular pathological changes and development of ischaemic vascular disease, which is often followed by smooth muscle cell (SMC) proliferation and accumulation. If we could arbitrarily convert SMCs into endothelial cells (ECs), they may represent a promising new approach to achieve therapeutic angiogensis of ischaemic area. To test this hypothesis, the aim of the present study is to transdifferentiate human SMCs into functional ECs. Methods and results Human SMCs were first reprogrammed for 4 days to obtain a partially converted state, i.e. vascular progenitor, by introducing four transcription factors: Oct4, Sox2, Klf4 and c-Myc. These vascular progenitors were then subjected to defined media and culture conditions to induce endothelial lineage differentiation. The differentiated cells expressed EC markers such as CD31, CD144, and eNOS at the mRNA and protein level. Next, CD34 positive cells were selected from the heterogeneous population of vascular progenitors and further cultured in endothelial inducing conditions. The CD34+ cells were able to give rise to a more homogenous endothelial-like population in higher efficiency. The converted ECs displayed typical endothelial functional properties including acetylated-LDL uptake and tube formation in vitro and in vivo. More importantly, these ECs-derived from human SMCs exhibited therapeutic angiogenesis capacity which improved blood flow recovery when applied in the murine ischaemic hindlimb model. To explore the mechanisms involved in SMCs to ECs transdifferentiation, whole mRNAs from different reprogrammed cells were analysed by RNA-Sequencing techniques. Comprehensive analysis indicated that mesenchymal-to-epithelial transition was requisite to initiate SMCs reprogramming to vascular progenitor. Furthermore, it was demonstrated that hairy and enhancer of split 5 (HES5), a member of a family of basic helix-loop-helix transcriptional factor of the Notch signalling pathway, regulated progenitors to endothelial lineage differentiation. Conclusions In this study, we provided the first evidence of converting human SMCs towards functional EC lineage involving the mechanisms of mesenchymal-to-epithelial transition and the Notch signalling pathway. Furthermore, the converted ECs displayed a therapeutic capacity of angiogenesis in a murine ischaemic model.

Contractile Smooth Muscle Cells Derived from Hair-Follicle Stem Cells.

Human Hair Follicle Stem Cell Differentiation into Contractile Smooth Muscle Cells is Induced by Transforming Growth Factor-Β1 and Platelet-Derived Growth Factor BB.

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture.

Preliminary Study on Inducing Hair Follicle Stem Cells into Vascular Smooth Muscle Cells in Vitro

Differentiation of Adipose-Derived Stem Cells into Contractile Smooth Muscle Cells Induced by Transforming Growth Factor-Beta 1 and Bone Morphogenetic Protein-4

Transdifferentiation of human endothelial progenitors into smooth muscle cells

Derivation of Functional Smooth Muscle Cells from Integration-Free Induced Pluripotent Stem Cells Through Cardiovascular Progenitor Cell Intermediates for Vascular Regeneration

Smooth Muscle Cells Differentiated from Reprogrammed Embryonic Lung Fibroblasts Through DKK3 Signaling Are Potent for Tissue Engineering of Vascular Grafts.

Smooth muscle progenitor cells and cardiovascular disease

Transdifferentiated Human Vascular Smooth Muscle Cells Are A New Potential Cell Source for Endothelial Regeneration

[Experiment of Adipose Derived Stem Cells Induced into Smooth Muscle Cells].

Construction of Vascular Tissues with Macro-Porous Nano-Fibrous Scaffolds and Smooth Muscle Cells Enriched from Differentiated Embryonic Stem Cells.

Abstract 650: Stem Cell-derived SMCs Are Useful for Vascular Tissue Engineering

VEGF165 induces differentiation of hair follicle stem cells into endothelial cells and plays a role in in vivo angiogenesis.

Engineering of the Human Vessel Wall with Hair Follicle Stem Cells in Vitro.

Identification and function assessment of smooth muscle cells derived from mouse embryonic stem cells

222 Generation of Functional Endothelial-Like Cells Enabling Therapeutic Angiogenesis from Human Smooth Muscle Cells

Human Hair Follicle-Derived Mesenchymal Stem Cells: Isolation, Expansion, and Differentiation

In vitro culture and migration assay of mouse smooth muscle progenitor cells

Differentiation of Human Hair Follicle Stem Cells into Endothelial Cells Induced by Vascular Endothelial and Basic Fibroblast Growth Factors.